Latest News for IDIA.SW
The findings demonstrate that aprocitentan may help reduce the risk of kidney disease progression, cardiovascular events, and mortality in patients with resistant hypertension. Allschwil, Switzerland - June 01, 2026Idorsia Ltd (SIX: IDIA) announces new analyses from the Phase 3 PRECISION study demonstrating that aprocitentan, Idorsia's dual endothelin receptor antagonist, significantly reduces albuminuria and…
Ad-hoc-Mitteilung gemäss Art. 53 KR. Pratteln, Schweiz, 30. April 2026 - Santhera Pharmaceuticals (SIX: SANN) schlägt vor, Dr. Srishti Gupta, MD, MPP, MPhil, auf der bevorstehenden ordentlichen Generalversammlung am 26.
Ad hoc announcement pursuant to Art. 53 LR. Pratteln, Switzerland, April 30, 2026 - Santhera Pharmaceuticals (SIX: SANN) proposes to elect Dr. Srishti Gupta, MD, MPP, MPhil, as an Independent Director at the upcoming Annual General Meeting to be held on May 26, 2026.
🧮 Earnings Move Analyzer
Insider Trading
No insider trades found for IDIA.SW.
Senate Trading
No Senate trades found for IDIA.SW.
U.S. House Trading
No House trades found for IDIA.SW.
Options Chain
Select an expiration to expand. Bid/Ask are shown first (before Mark) on both sides.